FDA News

Your daily dose of the clinical news you may have missed.

FDA panel endorses continued use of monovalent JN.1 strain for COVID-19 vaccines, aligning with global health recommendations amid evolving variants.

Your daily dose of the clinical news you may have missed.

Mepolizumab, an IL-5 inhibitor targeting Th2 inflammation characterized by elevate serum eosinophil count, fills a treatment gap for ~70% of adults with uncontrolled COPD.

The diagnostic is designed to help clinicians determine the likelihood of cerebral β-amyloid plaque deposition, one of the neuropathologic hallmarks of AD.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Northstrive Biosciences received positive FDA feedback for its IND application for EL-22, a probiotic-based treatment for obesity.

A quick look at the states ranking highest and lowest on metrics including influenza vaccination, tetanus vaccination, HPV vaccination, and more.

Dupilumab (Dupixent) is the first new targeted therapy for CSU in over a decade.